Tripletail Wealth Management’s BriaCell Therapeutics BCTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BCTX
Tripletail Wealth Management's BCTX Position: Q3 2026 in Review
Tripletail Wealth Management opened a new position in BriaCell Therapeutics (BCTX) in Q3 2026: 30,000 shares worth $128K. The stake represents 0.15% of the portfolio and ranks #109 among its holdings.
19 funds tracked by Wall St. Rank hold BCTX as of Q3 2026.
- Tripletail Wealth Management held 30,000 shares of BriaCell Therapeutics worth $128K as of Q3 2026.
- BriaCell Therapeutics was a new Tripletail Wealth Management position in Q3 2026.
- BriaCell Therapeutics made up 0.15% of Tripletail Wealth Management's portfolio in Q3 2026, its #109 holding.
- 19 funds tracked by Wall St. Rank held BriaCell Therapeutics as of Q3 2026.
Based on Tripletail Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.